Clinical trial
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
NCT01808560 is registered in ClinicalTrials.gov with TearScience, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
- Lead sponsor
- TearScience, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- January 31, 2015
- Enrollment
- 34 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
blepharitis, dry eye syndrome